Similarly, although FLT3 amplifications may not be as commonly reported as some other mutations, this broader presence across various tumor types suggests a potentially significant role for FLT3 amplification not only in carcinogenesis but also in targeted therapies despite its relatively low incidence. Here, FLT3 is linked to neoplasm.